Published in J Bacteriol on November 01, 1964
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
Extrachromosomal inheritance in bacteria. Bacteriol Rev (1969) 13.40
Transposition of R factor genes to bacteriophage lambda. Proc Natl Acad Sci U S A (1975) 9.28
Phylogenetic relationships of drug-resistance factors and other transmissible bacterial plasmids. Bacteriol Rev (1968) 9.19
Coliphage P1-mediated transduction of cloned DNA from Escherichia coli to Myxococcus xanthus: use for complementation and recombinational analyses. J Bacteriol (1983) 2.73
Genome of bacteriophage P1. J Bacteriol (2004) 2.15
Indirect ultraviolet-reactivation of phage lambda. Proc Natl Acad Sci U S A (1974) 2.09
Acquisition of a determinant for chloramphenicol resistance by coliphage lambda. Proc Natl Acad Sci U S A (1975) 1.93
Cellular release of heat-labile enterotoxin of Escherichia coli by bacteriophage induction. Infect Immun (1978) 1.85
DRUG RESISTANCE OF STAPHYLOCOCCI. I. TRANSDUCTION OF TETRACYCLINE RESISTANCE WITH PHAGE LYSATES OBTAINED FROM MULTIPLY RESISTANT STAPHYLOCOCCI. J Bacteriol (1965) 1.83
Host participation in plasmid maintenance: dependence upon dnaA of replicons derived from P1 and F. Proc Natl Acad Sci U S A (1986) 1.79
Genetic and physical map of a P1 miniplasmid. J Bacteriol (1982) 1.77
Isolation and characterization of P1 minireplicons, lambda-P1:5R and lambda-P1:5L. J Bacteriol (1983) 1.61
Location of the multivalent control site for the ilvEDA operon of Escherichia coli. J Bacteriol (1980) 1.41
Test of the virulence and live-vaccine efficacy of auxotrophic and galE derivatives of Salmonella choleraesuis. Infect Immun (1987) 1.35
Mutants of Escherichia coli defective for replicative transposition of bacteriophage Mu. J Bacteriol (1986) 1.33
Drug resistance of enteric bacteria. VI. Introduction of bacteriophage P1CM into Salmonella typhi and formation of PldCM and F-CM elements. J Bacteriol (1966) 1.32
Additive recombination in bacteria. Bacteriol Rev (1977) 1.26
Genetic studies of coliphage P1. I. Mapping by use of prophage deletions. J Virol (1975) 1.17
Viral R plasmid Rphi6P: properties of the penicillinase plasmid prophage and the supercoiled, circular encapsidated genome. J Bacteriol (1978) 1.16
Construction of intergeneric hybrids using bacteriophage P1CM: transfer of the Klebsiella aerogenes ribitol dehydrogenase gene to Escherichia coli. J Bacteriol (1976) 1.15
Formation of recombinants between nontransmissible drug-resistance determinants and transfer factors. J Bacteriol (1969) 1.12
phiX174 DNA-dependent DNA synthesis in vitro: requirement for P1 ban protein in dnaB mutant extracts of Escherichia coli. Proc Natl Acad Sci U S A (1975) 1.11
Tn2001, a transposon encoding chloramphenicol resistance in Pseudomonas aeruginosa. J Bacteriol (1981) 1.07
Genetic studies of coliphage P1. III. Extended genetic map. J Virol (1976) 1.04
Tellurite susceptibility and non-plasmid-mediated resistance in Escherichia coli. Antimicrob Agents Chemother (1986) 1.02
A phage P1 function that stimulates homologous recombination of the Escherichia coli chromosome. Proc Natl Acad Sci U S A (1986) 0.96
Effect of bacteriophage P1 lysogeny on lipopolysaccharide composition and the lambda receptor of Escherichia coli. J Bacteriol (1984) 0.94
Suppression of induction of SOS functions in an Escherichia coli tif-1 mutant by plasmid R100.1. J Bacteriol (1980) 0.93
Maintenance of bacteriophage P1 plasmid. J Virol (1977) 0.93
Characterization of a P1-like bacteriophage carrying an SHV-2 extended-spectrum β-lactamase from an Escherichia coli strain. Antimicrob Agents Chemother (2014) 0.93
Salmonella choleraesuis strains deficient in O antigen remain fully virulent for mice by parenteral inoculation but are avirulent by oral administration. Infect Immun (1990) 0.91
Bacteriophage P1 gene 10 is expressed from a promoter-operator sequence controlled by C1 and Bof proteins. J Bacteriol (1992) 0.90
The c4 repressor of bacteriophage P1 is a processed 77 base antisense RNA. Nucleic Acids Res (1992) 0.90
Mutants of plasmid prophage P1 and elevated copy number: isolation and characterization. J Bacteriol (1982) 0.90
Lysogenic conversion of Pasteurella by Escherichia coli bacteriophage P1 CM. J Virol (1972) 0.88
Intracellular localization and effects on cell division of a plasmid blocked in deoxyribonucleic acid replication. J Bacteriol (1977) 0.87
IS1-dependent generation of high-copy-number replicons from bacteriophage P1 Ap Cm as a mechanism of gene amplification. J Bacteriol (1986) 0.80
Effects of mutations in the immunity system of bacteriophage P1. J Virol (1977) 0.80
Prophage substitution and prophage loss from superinfected Escherichia coli recA(P1) lysogens. J Virol (1979) 0.79
Transduction of plasmid determinants in Staphylococcus aureus and Escherichia coli. J Bacteriol (1978) 0.79
Phenotypic reversion of an IS1-mediated deletion mutation: a combined role for point mutations and deletions in transposon evolution. EMBO J (1982) 0.78
Dual regulatory control of a particle maturation function of bacteriophage P1. J Bacteriol (2001) 0.78
Restoration of F' superinfection inhibition in a DnaB mutant of Escherichia coli upon construction of heterozygous DnaB merodiploids or P1 lysogens carrying a dnaB analogue. J Bacteriol (1975) 0.77
Curing of P1 prophage from Escherichia coli K-12 recA(P1) lysogens superinfected with P1 bacteriophage. J Virol (1981) 0.77
Chloramphenicol transposons found in Salmonella naestved and Escherichia coli of domestic animal origin. Antimicrob Agents Chemother (1981) 0.75
Transduction of linked genetic characters of the host by bacteriophage P1. Virology (1955) 71.88
Studies on lysogenesis. I. The mode of phage liberation by lysogenic Escherichia coli. J Bacteriol (1951) 28.27
EQUILIBRIUM SEDIMENTATION OF MACROMOLECULES IN DENSITY GRADIENTS. Proc Natl Acad Sci U S A (1957) 25.31
Genetic exchange in Salmonella. J Bacteriol (1952) 23.68
Infective heredity of multiple drug resistance in bacteria. Bacteriol Rev (1963) 19.90
Agar layer method for production of high titer phage stocks. Proc Soc Exp Biol Med (1951) 12.04
Transduction of lactose-utilizing ability among strains of E. coli and S. dysenteriae and the properties of the transducing phage particles. Virology (1960) 11.82
Transduction in Escherichia Coli K-12. Genetics (1956) 7.54
Transduction of chromosomal genes and episomes in Escherichia coli. Virology (1960) 7.41
Episome-mediated transfer of drug resistance in Enterobacteriaceae. III. Transduotion of resistance factors. J Bacteriol (1961) 5.78
Radiological evidence for partial genetic homology between bacteriophage and host bacteria. Virology (1955) 5.51
Resistance transfer agents in Shigella. Biochem Biophys Res Commun (1960) 5.28
I. : Lysogenic Conversions in Bacteria. Bacteriol Rev (1959) 3.26
Specialized transduction of tryptophan markers in Escherichia coli K12 by bacteriophage phi-80. Virology (1963) 3.20
Transduction of lysogeny in Escherichia coli. Virology (1955) 2.81
[Defectiveness of lambda phage transductor]. Schweiz Z Pathol Bakteriol (1957) 2.44
Transduction and segregation in Escherichia coli K12. Virology (1957) 2.42
Conversion of somatic antigens in Salmonella by phage infection leading to lysis or lysogeny. Virology (1958) 2.15
Drug-resistance of enteric bacteria. 12. Transduction of the transmissible drug resistance factor by bacteriophage Plkc. Jpn J Exp Med (1962) 1.84
TRANSDUCTION BY BACTERIOPHAGE P1: ABNORMAL PHAGE FUNCTION OF THE TRANSDUCING PARTICLES. Proc Natl Acad Sci U S A (1958) 1.73
DRUG RESISTANCE OF ENTERIC BACTERIA. II. TRANSDUCTION OF TRANSMISSIBLE DRUG-RESISTANCE (R) FACTORS WITH PHAGE EPSILON. J Bacteriol (1963) 1.60
The specific gravity of transducing particles of bacteriophage P1. Virology (1962) 1.51
Studies on lysogenesis. II. The effect of temperature on the lysogenization of Shigella dysenteriae with phage P1. J Bacteriol (1954) 1.47
Density gradient centrifugation of bacteriophage P22. Virology (1962) 1.14
[A defect of transducing Salmonella phage P22]. Z Naturforsch B (1958) 1.02
Mutants of Salmonella phage e 15 with abnormal conversion properties. Virology (1959) 0.94
ELIMINATION OF DRUG RESISTANCE OF STAPHYLOCOCCUS AUREUS BY TREATMENT WITH ACRIFLAVINE. J Bacteriol (1963) 4.41
Experimental salmonellosis. Intracellular growth of Salmonella enteritidis ingested in mononuclear phagocytes of mice, and cellular basis of immunity. J Bacteriol (1961) 3.58
On the drug-resistance of enteric bacteria. 2) Transmission of the drug-resistance among Enterobacteriaceae. Jpn J Exp Med (1960) 3.42
ELIMINATION OF PENICILLIN RESISTANCE OF STAPHYLOCOCCUS AUREUS BY TREATMENT WITH ACRIFLAVINE. J Bacteriol (1964) 3.03
Elimination of transmissible drug-resistance by treatment with acriflavin. Nature (1961) 3.03
Multiple resistance of enteric bacteria and transmission of drug-resistance to other strain by mixed cultivation. Jpn J Exp Med (1960) 2.83
Studies on the experimental typhoid. 1. A comparative study of living and killed vaccines against the infection of mice with S. enteritidis. Jpn J Exp Med (1958) 2.83
DRUG RESISTANCE OF STAPHYLOCOCCI. II. JOINT ELIMINATION AND JOINT TRANSDUCTION OF THE DETERMINANTS OF PENICILLINASE PRODUCTION AND RESISTANCE TO MACROLIDE ANTIBIOTICS. J Bacteriol (1965) 2.25
Inhibition of Salmonella enteritidis ingested in mononuclear phagocytes from liver and subcutaneous tissue of mice immunized with live vaccine. J Bacteriol (1962) 2.25
Aromatic biosynthesis. XII. Conversion of 5-dehydroquinic acid to 5-dehydroshikimic acid dy 5-dehydroquinase. Biochim Biophys Acta (1954) 2.20
Combination of two types of transmissible drug-resistance factors in a host bacterium. J Bacteriol (1962) 2.01
On the drug-resistance of enteric bacteria. 3. Transmission of the drug-resistance from Shigella to F--or Hfr strains of E.coli K-12. Jpn J Exp Med (1960) 1.89
Conversion of D-xylose to D-xylulose in extracts of Lactobacillus pentosus. J Biol Chem (1953) 1.85
Drug-resistance of enteric bacteria. 12. Transduction of the transmissible drug resistance factor by bacteriophage Plkc. Jpn J Exp Med (1962) 1.84
DRUG RESISTANCE OF STAPHYLOCOCCI. I. TRANSDUCTION OF TETRACYCLINE RESISTANCE WITH PHAGE LYSATES OBTAINED FROM MULTIPLY RESISTANT STAPHYLOCOCCI. J Bacteriol (1965) 1.83
On the drug-resistance of enteric bacteria. 6. Spontaneous and artificial elimination of transmissible drug-resistance factors. Jpn J Exp Med (1961) 1.80
Antilethal resistance of mice immunized with liver vaccine against infection with Salmonella enteritidis. Jpn J Exp Med (1960) 1.75
Drug-resistance of enteric bacteria. 5. Drug-resistance of Escherichia coli isolated from human being. Jpn J Exp Med (1961) 1.70
DRUG RESISTANCE OF ENTERIC BACTERIA. 3. ACQUISITION OF TRANSFERABILITY OF NONTRANSMISSIBLE R(TC) FACTOR IN COOPERATION WITH F FACTOR AND FORMATION OF FR(TC). J Bacteriol (1964) 1.68
Studies on the experimental salmonellosis. VI. Longlasting immunity of mouse immunized with live vaccine of Salmonella enteritidis. Jpn J Exp Med (1961) 1.66
Decomposition of thioether derivatives by bacteria; methylmercaptan formation and the properties of the responsible enzyme. Jpn J Exp Med (1949) 1.63
DRUG RESISTANCE OF ENTERIC BACTERIA. II. TRANSDUCTION OF TRANSMISSIBLE DRUG-RESISTANCE (R) FACTORS WITH PHAGE EPSILON. J Bacteriol (1963) 1.60
On the drug-resistance of enteric bacteria. 4. Drug-resistance of Shigella prevalent in Japan. Jpn J Exp Med (1961) 1.55
Studies on the experimental typhoid. IV. The microorganisms in the organs of infected mice. Jpn J Exp Med (1959) 1.36
[On the drug resistance of enteric bacteria. 5. Mechanisms of the transmission of drug resistance between Shigella and E. coli]. Nihon Saikingaku Zasshi (1961) 1.30
Studies on the experimental typhoid. II. Relation between virulence and antigenic structure of virulent and attenuated strains of S. enteritidis. Jpn J Exp Med (1959) 1.28
Aromatic biosynthesis. XIII. Conversion of quinic acid to 5-dehydroquinic acid by quinic dehydrogenase. Biochim Biophys Acta (1954) 1.28
EXPERIMENTAL SALMONELLOSIS. III. NEW TOXIC FRACTION (L) OBTAINED FROM SALMONELLA ENTERITIDIS AND ITS IMMUNOLOGICAL PROPERTIES. J Bacteriol (1963) 1.27
Studies on the drug-resistance of enteric bacteria. 10. Relation between transmissible drug-resistance (R) factor and fertility (F) factor in E. coli strain K-12. Jpn J Exp Med (1961) 1.14
EXPERIMENTAL SALMONELLOSIS. IV. LIPID CONTENT OF TOXIN L OBTAINED FROM SALMONELLA ENTERITIDIS. J Bacteriol (1965) 0.99
[STUDIES ON CELLULAR IMMUNITY]. Arerugi (1964) 0.93
Studies on the Habu snake venom. 3-2. A comparative study of histopathological changes caused by crude venom, purified Habu-proteinase and other proteinases. Jpn J Microbiol (1960) 0.90
Studies on Habu snake venom. (V). Myolysis caused by phospholipase A in Habu snake venom. Jpn J Exp Med (1962) 0.85
On the fractionation of complex components of Mycobacterium tuberculosis and their biological properties. Jpn J Med Sci Biol (1960) 0.85
MUTANT OF SALMONELLA PHAGE EPSILON 34 WITH LOSS OF CONVERTING ABILITY. Jpn J Microbiol (1964) 0.81
INFECTION OF GERMEREE MICE WITH SHIGELLA FLEXNERI 3A. Jpn J Exp Med (1964) 0.81
Studies on the drug resistance of enteric bacteria. 9. Transmission of the drug-resistance factor between spheroplasts. Jpn J Exp Med (1961) 0.79
[STUDY ON THE DRUG-RESISTANCE OF STAPHYLOCOCCI]. J Antibiot B (1964) 0.79
Studies on the experimental typhoid. III. Histopathological study of the mice liver infected with virulent or attenuated S. enteritidis strain. Jpn J Exp Med (1959) 0.79
Studies on Habu snake venom. 2b. Further purification and enzymic and biological activities of H alpha-proteinase. Jpn J Microbiol (1959) 0.78
Studies on the improvement of treatment of Habu snake (Trimeresurus flavoviridis) bite. 3. Clinical analysis and medical treatment of Habu snake bite on the Amami Islands. Jpn J Exp Med (1962) 0.77
End results of focal debridement in bone and joint tuberculosis and its indications. J Bone Joint Surg Am (1957) 0.76
Studies on Habu snake venom. 2c. Studies on H beta-proteinase of Habu venom. Jpn J Microbiol (1960) 0.76
[Studies on Trimeresurus venom. 1b) Comparison of the toxicological action of the venoms of Trimeresurus flavoviridis Hallowell, Tremeresurus elegans Gray and Trimeresurus okinavensis Boulenger]. Nihon Saikingaku Zasshi (1961) 0.76
[Studies on drug resistance of enteric bacteria. 11. Effect of protease and nucleic acid-splitting enzymes]. Nihon Saikingaku Zasshi (1961) 0.75
[Studies on experimental typhoid. 8c) Intracellular inhibition of the growth of S. typhi murium, S. cholerae suis, and E. coli O-55 in mononuclear phagocytes from the abdominal cavity of mice super-immunized with live Salmonella enteritidis vaccine]. Nihon Saikingaku Zasshi (1961) 0.75
[Clinical aspects of cardiac asthma]. Naika (1962) 0.75
Formation of hydrogen suifide by the decomposition of thiosulfate by bacteria. III. Jpn J Exp Med (1957) 0.75
[Studies on experimental typhoid. 8g. On the appearance and duration of cellular immunity (in the mouse immunized with live Salmonella enteritidis vaccine)]. Nihon Saikingaku Zasshi (1962) 0.75
Studies on Habu snake venom. I. Comparison of several biological activities of fresh and dried Habu snake venom. Jpn J Microbiol (1959) 0.75
On the commissura postoptica in the brain of a newt, Triturus pyrrhogaster. Okajimas Folia Anat Jpn (1955) 0.75
[Studies on the drug resistance of enteric bacteria. 17. On a study of drug-resistant Escherichia coli]. Nihon Saikingaku Zasshi (1962) 0.75
Study on a new strain of the pathogenic Vibrio isolated from fresh-water fishes. Jpn J Microbiol (1958) 0.75
[On the drug resistance of enteric bacteria. 6. Transmissibility of multiple drug resistance among Citrobacter, Shigella and E. coli]. Nihon Saikingaku Zasshi (1961) 0.75
On the commissural systems of the cerebellum in Megalobatrachus japonicus. Okajimas Folia Anat Jpn (1956) 0.75
Studies on Habu snake venom. IV. Fractionation of Habu snake venom by chromatography on CM-cellulose. J Biochem (1961) 0.75
Measurement of extent of increased capillary permeability. Jpn J Microbiol (1960) 0.75
[ANTIBACTERIAL ACTION OF LINCOMYCIN ON STAPHYLOCOCCI]. J Antibiot B (1965) 0.75
Isolation and identification of glyceryl monomycolate and of mycolic acid in phosphatide fraction of BCG. Jpn J Med Sci Biol (1960) 0.75
Focal debridement in tuberculosis of the spine. Acta Sch Med Univ Kioto (1960) 0.75
[EPIDEMIOLOGICAL STUDY ON THE TRANSMISSIBLE DRUG-RESISTANCE R FACTOR]. J Antibiot B (1964) 0.75
[Studies on the drug resistance of enteric bacteria. 8. Comparison of the sulfonamide resistance in strains resistant to single and multiple sulfonamides obtained from nature]. Nihon Saikingaku Zasshi (1961) 0.75
Studies on the improvement of treatment of Habu snake (Trimeresurus flavoviridis) bite. 2. Antitoxic action of monocalcium disodium ethylene diamine tetraacetate on Habu venom. Jpn J Exp Med (1961) 0.75
[THE PREDISPOSITION OF CELLULAR IMMUNITY: A SYMPOSIUM ON ITS SIGNIFICANCE IN MEDICINE]. Saishin Igaku (1965) 0.75
[Studies on the drug resistance of enteric bacteria. 16) On multiple resistant E. coli isolated from humans in the Tokyo area]. Nihon Saikingaku Zasshi (1961) 0.75
[Studies on the drug resistance of enteric bacteria. 14. On artificial elimination of transmissible drug-resistance by means of acriflavine]. Nihon Saikingaku Zasshi (1962) 0.75
[Measurement of the extent of increased capillary permeability]. Nihon Saikingaku Zasshi (1961) 0.75
Chemistry of phosphatide and wax D of Mycobacterium tuberculosis BCG in one week culture. Jpn J Med Sci Biol (1960) 0.75
Studies on the improvement of treatment of Habu snake bite. I. Studies on the improvement of Habu snake antivenin. Jpn J Exp Med (1961) 0.75
[Studies on the drug resistance of enteric bacteria. 13. On sensitivity due to natural elimination by cold storage of the transmissible resistance to 4 drugs]. Nihon Saikingaku Zasshi (1962) 0.75
[Studies on experimental typhoid. 1. Differences in the reaction of the mouse liver to immunization with live or dead Salmonella enteritidis vaccine]. Nihon Saikingaku Zasshi (1961) 0.75
REPORT OF TWO CASES OF NON-MALATIC ISCHEMIC MYOCARDIAL FIBROSIS. Acta Pathol Jpn (1963) 0.75
[Studies on the drug resistance of enteric bacteria. On the factor conferring resistance to 4 drugs (R-MF31) isolated from several types of R factor]. Nihon Saikingaku Zasshi (1962) 0.75
[Studies on experimental salmonellosis. 8f. In vitro transfer of cellular immunity]. Nihon Saikingaku Zasshi (1962) 0.75
[STUDIES OF RENOSCINTIGRAM. 1. SIGNIFICANCE OF AREA-SCANNING]. Nihon Hinyokika Gakkai Zasshi (1963) 0.75
Experimental studies on Habu snake venom. III-3. Experimental histopathological studies on the central nerve system in guinea pigs. Jpn J Microbiol (1960) 0.75
[Studies on experimental typhoid--especially on the relation between the mouse and Gartner's bacillus. IXb) Distribution of bacteria of the virulent strain of Salmonella enteritidis in the organs of the infected mouse]. Nihon Saikingaku Zasshi (1961) 0.75
[Intracellular infection. 3) On morphological changes in L-cells after contact with S. enteritidis]. Nihon Saikingaku Zasshi (1961) 0.75
[GENETIC ASPECTS OF BACTERIA AND NUCLEIC ACIDS WITH SPECIAL REFERENCE TO DRUG-RESISTANCE]. Sogo Igaku (1963) 0.75
[Cellular infection. 1. Salmonella enteritidis infection of L cells from the mouse]. Nihon Saikingaku Zasshi (1961) 0.75
DRUG-RESISTANCE OF STAPHYLOCOCCI. 3. IMPAIRMENT OF ANTIMICROBIAL ACTIVITY OF STREPTOMYCIN BY INCREASE IN SALT CONCENTRATION. Gunma J Med Sci (1964) 0.75
[Studies on the drug resistance of enteric bacteria. 12. Experimental isolation of the transmissible chloramphenicol-resistant factor]. Nihon Saikingaku Zasshi (1961) 0.75
Studies of H beta-proteinase of Habu snake venom, with special reference to substrate specificity and inhibitory effect of serum. J Biochem (1961) 0.75
Operative treatment of bone-joint tuberculosis. Acta Tuberc Jpn (1951) 0.75
Transmissible drug-resistance factors and formation of multiple resistance. Nature (1962) 0.75
STUDIES ON HABU SNAKE VENOM. VI. CYTOTOXIC EFFECT OF HABU (TRIMERESURUS FLAVOVIRIDIS HALLOWELL) AND COBRA (NAJA NAJA) VENOMS ON THE CELLS IN VITRO. Jpn J Exp Med (1964) 0.75
Studies on Habu snake venom. 2. Enzymic studies on the proteinase of Habu snake venom. Jpn J Microbiol (1959) 0.75
[Studies on experimental salmonellosis. 8d. Effect of immune serum on the growth of Salmonella enteritidis in the mononuclear phagocytes in the mouse abdomen]. Nihon Saikingaku Zasshi (1961) 0.75
Studies on phagocytes. I. The use of 2,3,5, triphenyl-tetrazoliumchloride as a measure of the activity of phagocytes. Jpn J Exp Med (1958) 0.75
[On the comparison of local lesions in muscles of mice injected with venom from Trimeresurus flavoviridis Hallowell, Trimeresurus elegans Gray, and Trimeresurus okinavensis Boulenger]. Nihon Saikingaku Zasshi (1961) 0.75
[STUDIES OF RENOSCINTIGRAM. 2. METABOLISM OF HG-203 NEOHYDRIN]. Nihon Hinyokika Gakkai Zasshi (1963) 0.75
[Studies on experimental typhoid. 2. Nodule formation in the liver of the mouse immunized with dead vaccine of Escherichia coli]. Nihon Saikingaku Zasshi (1961) 0.75